Adenocarcinoma × Lymphoid × Clear all
NCT04028479 2024-12-18

ROOT

Taproot Health

Completed
167 enrolled
NCT00154388 2016-11-18

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Novartis

Phase 2 Completed
185 enrolled